Secretome Therapeutics
Biotechnology Research
323 W Camden St
14 employees
- Employees
- 14
- Contacts
- 3
- Emails
- 3
- Phones
- 2
Secretome Therapeutics Overview
- Headquarters
- 323 W Camden St
- Website
- neoprogen.com
- Industry
- Biotechnology Research
- Employees
- 14
- Founded
- 2018
- Funding
- 20.4M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Secretome Therapeutics
Revolutionizing cell therapy to address inflammatory diseases driven via neonatal cardiac progenitor cells and their secretomes.
Secretome Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 2
- 50.0% coverage
Secretome Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Jeff Masten Mba | Transformative Biotech C-suite Leader | Las Vegas, Nevada, United States |
View
|
| Salman Bhai | Vice President Clinical Development @ | Dallas-fort Worth Metroplex, United States |
Email
|
| Vinny Jindal | President and CEO | Dallas-fort Worth Metroplex, United States |
Email
Phone
|
| Bill Niland | CEO Regeltec | Baltimore, Maryland, United States |
Email
Phone
|
Employees by Management Level
Executive
3 profiles
Individual contributor
1 profile
Compare Similar Companies to Secretome Therapeutics
Sarepta Therapeutics
Biotechnology Research
Arrowhead Pharmaceuticals
Biotechnology Research
Genethon
Biotechnology Research
StemCyte Inc.
Biotechnology Research
Cellipont Bioservices
Biotechnology Research
Wugen
Biotechnology Research
Vyriad
Biotechnology
March Biosciences
Biotechnology
COEPTIS, Inc
Pharmaceutical Manufacturing
SineuGene Therapeutics
Pharmaceutical Manufacturing